OPA1 Mutations in Patients with Autosomal Dominant Optic Atrophy and Evidence for Semi-dominant Inheritance
Overview
Molecular Biology
Affiliations
We and others have shown recently that mutations in the OPA1 gene encoding a dynamin-related mitochondrial protein cause autosomal dominant optic atrophy (ADOA) linked to chromosome 3q28-q29. Here we report screening of the OPA1 gene in a sample of 78 independent ADOA families. OPA1 mutations were identified in 25 patients (detection rate 32.1%) including 16 novel mutations. We successfully amplified OPA1 cDNA prepared from leukocyte RNA of three patients, and found the amount of transcripts harboring the Arg366Stop mutation was significantly reduced compared with transcripts derived from the normal chromosome. Analysis of the distribution of OPA1 mutations in ADOA revealed that most missense mutations cluster within the putative GTPase domain, and that there is a preponderance of mutations, which result in premature translation termination. These observations support the notion that haploinsufficiency may represent a major pathomechanism for ADOA. In addition, we identified an ADOA patient who is a compound heterozygote for two OPA1 missense mutations. The fact that this patient is by far more severely affected than her simple heterozygotic parents and siblings implies that at least these OPA1 alleles behave semi-dominantly rather than purely dominantly. Clinical examination revealed considerable variability in disease expression among patients carrying OPA1 mutations and no strict correlation with either the position or the type of mutation.
Mitochondrial diseases: from molecular mechanisms to therapeutic advances.
Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.
PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.
Chermakani P, Gowri P, Mahesh Kumar S, Sundaresan P EXCLI J. 2023; 22:1077-1091.
PMID: 38054206 PMC: 10694345. DOI: 10.17179/excli2023-6297.
Mechanisms of Modulation of Mitochondrial Architecture.
Munoz J, Basei F, Rojas M, Galvis D, Zorzano A Biomolecules. 2023; 13(8).
PMID: 37627290 PMC: 10452872. DOI: 10.3390/biom13081225.
OPA1, a molecular regulator of dilated cardiomyopathy.
Chen J, Shao J, Wang Y, Wu K, Huang M J Cell Mol Med. 2023; 27(20):3017-3025.
PMID: 37603376 PMC: 10568666. DOI: 10.1111/jcmm.17918.
Guo L, Xie X, Wang J, Xiao H, Li S, Xu M Cells. 2023; 12(15).
PMID: 37566030 PMC: 10416940. DOI: 10.3390/cells12151951.